A Clinical Study Comparatively Evaluating the Pharmacokinetics, Pharmacodynamics and Safety of Intravenous Administration of HSK3486 Injectable Emulsion in Patients With Chronic Renal Impairment and Subjects With Normal Renal Functions

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Dec 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cipepofol (Primary)
Indications Anaesthesia
Focus Pharmacokinetics
Sponsors Sichuan Haisco Pharmaceutical

Most Recent Events

16 Dec 2020 Status changed from recruiting to completed.
22 Jul 2020 Planned End Date changed from 30 Jun 2020 to 30 Aug 2020.
22 Jul 2020 Planned primary completion date changed from 30 Jun 2020 to 30 Aug 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight